Equity boost of €590m lifts WS Audiology to better focus on delivering growth
Denmark-based WSA, a hearing-aid-only business behind two big brands - Widex and Signia - has announced spring blossoms to help its long-term plans and soothe debt pressure: in addition to an equity capital injection, the group is welcoming a new partner from Germany.

©WSA
WS Audiology HG in Lynge, Denmark
WS Audiology (WSA) has announced German healthcare outfit ATHOS KG as a new minority shareholder, joining the group's other investors: T&W Medical, EQT, and the Lundbeck Foundation. WSA's governance set-up remains unchanged.
In another key April development, the group that parents the Widex and Signia hearing aid brands has welcomed an equity capital injection of some €590 million in total from its existing and new shareholders to further support the company’s successful growth trajectory and long-term strategic ambitions.
Who are ATHOS?
ATHOS KG is a Munich based single family office with a history in healthcare and life sciences, investing in teams with exceptional science expertise and technology-driven companies with an entrepreneurial and value-based approach.
Lars Rasmussen, Chair of WSA, said "I am pleased to welcome ATHOS as a shareholder of WSA. With T&W Medical, EQT, the Lundbeck foundation...
This content is reserved for subscribers to Audiology Worldnews
Already subscribed Log in